MedTrace Logo

Goal-setting in Stroke: From Guideline Towards Implementation: a Realist Evaluation

NCT06065397 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 280

Last updated 2023-10-03

No results posted yet for this study

Summary

Overall objective: The aim of the project is to integrate the quality improvement programme on goal setting into the current care of people with stroke and to test and refine this programme.

Target group:

1. People after a stroke (treatment in the participating centres); total number 155 people
2. Informal carers (only if the person has had a stroke and has limited opportunities to participate)
3. Professional carer; total number 155 people

What?

The goal-setting programme becomes standard care, it is checked whether the programme has been applied in care by health professionals (review of the patient's medical record), what the effects are on patients (questionnaires) and health professionals (questionnaires) and whether the quality improvement programme needs to be adjusted or refined (interviews with health professionals and the patient group)

When to evaluate?

1. Health professionals: start of the study and end of the study via questionnaires. Interviews/focus group (every 3 months)
2. Review of patient records and observations (every 3 weeks)
3. Patient assessment: Admission and 1 week before discharge or end of study, Interviews/focus group (3 months)

Conditions

Interventions

PROCEDURE

Goal setting improvement program

A improvement program how to optimalize patient-centered goal setting in rehab care is being implemented.

Sponsors & Collaborators

  • Federal Public Service Health, Food Chain Safety and Environment

    collaborator UNKNOWN

  • Hasselt University

    lead OTHER

Principal Investigators

  • Annemie Spooren, prof dr · UHasselt

Study Design

Allocation
NON_RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-01-17
Primary Completion
2023-09-23
Completion
2024-03-30

Countries

  • Belgium

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06065397 on ClinicalTrials.gov